Dr. Schwartz joined the UCSF Department of Ophthalmology in 1990. He serves as Director of the Retina Division at the San Francisco VA Medical Center.

His research focuses on developing new therapies and diagnostics for eye disease.

With Drs. Robert Grubbs and Julia Kornfield at Caltech, he co-invented the Light Adjustable Lens, an intraocular lens whose power can be adjusted non-invasively using light during the post-operative period. FDA Approved in 2017, it optimizes vision without spectacles for patients who have had cataract surgery.

With Drs. Scott Fraser and Jeff Fingler, he co-invented OCT angiography, a non-invasive means of imaging the retinal and choroidal vasculature. OCT angiography is playing an increasingly important role in diagnosis and management of age-related macular degeneration, diabetic retinopathy, and other common retinovascular diseases.

Dr. Schwartz’s current efforts are directed at developing novel therapies for age-related macular degeneration and myopic macular degeneration.

He is grateful for the research support he has received from the NIH, Research Prevent Blindness, the Pritzker Family Fund, the Hellman Foundation, the Larry L. Hillblom Foundation, and many of his patients.